Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA.

Emerging Infectious Diseases
Preeta K KuttyL Clifford McDonald

Abstract

We determined estimated incidence of and risk factors for community-associated Clostridium difficile infection (CA-CDI) among patients treated at 6 North Carolina hospitals. CA-CDI case-patients were defined as adults (>18 years of age) with a positive stool test result for C. difficile toxin and no hospitalization within the prior 8 weeks. CA-CDI incidence was 21 and 46 per 100,000 person-years in Veterans Affairs (VA) outpatients and Durham County populations, respectively. VA case-patients were more likely than controls to have received antimicrobial drugs (adjusted odds ratio [aOR] 17.8, 95% confidence interval [CI] 6.6-48] and to have had a recent outpatient visit (aOR 5.1, 95% CI 1.5-17.9). County case-patients were more likely than controls to have received antimicrobial drugs (aOR 9.1, 95% CI 2.9-28.9), to have gastroesophageal reflux disease (aOR 11.2, 95% CI 1.9-64.2), and to have cardiac failure (aOR 3.8, 95% CI 1.1-13.7). Risk factors for CA-CDI overlap with those for healthcare-associated infection.

References

Jun 1, 1990·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·E BrownC Hoegg
Aug 1, 1983·Gut·C GreenfieldP Noone
Jun 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·T V RileyC L Golledge
Jan 1, 1994·The Journal of Infectious Diseases·L R HirschhornR Platt
Mar 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R FeketyM E Mulligan
Feb 10, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·O KarlströmL G Burman
Oct 20, 1998·The Journal of Hospital Infection·G E Bignardi
Feb 25, 2000·Clinical Therapeutics·D G LevyG W Elmer
Oct 6, 2001·Gastroenterology Clinics of North America·S D Lee, C M Surawicz
Jan 5, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lorraine KyneCiarán P Kelly
Feb 27, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Robert GaynesFred C Tenover
Sep 1, 2004·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Jacques PépinDaniel Chouinard
Dec 2, 2005·MMWR. Morbidity and Mortality Weekly Report·UNKNOWN Centers for Disease Control and Prevention (CDC)
Dec 3, 2005·The New England Journal of Medicine·L Clifford McDonaldDale N Gerding
Jan 18, 2006·JAMA : the Journal of the American Medical Association·Sandra DialSamy Suissa
May 18, 2006·Emerging Infectious Diseases·L Clifford McDonaldDaniel B Jernigan
Aug 16, 2006·International Journal of Antimicrobial Agents·David RavehAmos M Yinnon
Sep 27, 2006·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Sandra DialSamy Suissa
Mar 21, 2007·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Joseph F RodemannChristian D Stone
Apr 4, 2008·MMWR. Morbidity and Mortality Weekly Report·UNKNOWN Centers for Disease Control and Prevention (CDC)
Apr 9, 2008·American Journal of Obstetrics and Gynecology·Nadine G RouphaelL Clifford McDonald
Apr 25, 2008·The Journal of Antimicrobial Chemotherapy·M H WilcoxW N Fawley
Nov 4, 2008·The Lancet Infectious Diseases·Tim PlancheSanjeev Krishna
Jul 25, 2009·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M P BauerE J Kuijper
Sep 8, 2009·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Pascal J LambertGreg W Hammond
Mar 15, 2011·The American Journal of Medicine·Susanna NaggieChristopher W Woods

❮ Previous
Next ❯

Citations

Apr 18, 2012·Inflammatory Bowel Diseases·Adam M BergFrancis A Farraye
Jun 26, 2013·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Christian EckmannAxelle Beriot-Mathiot
Oct 12, 2012·Current Infectious Disease Reports·Jane A Cecil
May 15, 2013·International Journal of Antimicrobial Agents·Pierre TattevinChristian Michelet
Feb 7, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Robert C OwensCarlene A Muto
Jul 7, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Fernanda C LessaL Clifford McDonald
Mar 28, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Julia Shaklee SammonsTheoklis Zaoutis
Apr 27, 2013·The Journal of Antimicrobial Chemotherapy·Abhishek DeshpandeCurtis J Donskey
Jan 15, 2011·The Pediatric Infectious Disease Journal·Thomas J SandoraGrace M Lee
Dec 18, 2012·Current Opinion in Pediatrics·Julia Shaklee Sammons, Philip Toltzis
Feb 18, 2011·Journal of Clinical Microbiology·A L GalvánC del Aguila
Mar 1, 2013·Journal of Clinical Microbiology·Dolors Rodríguez-PardoUNKNOWN Barcelona Clostridium difficile Study Group
Feb 22, 2012·PLoS Medicine·Stephan Harbarth, Matthew H Samore
Jul 31, 2013·PloS One·Lucy A JuryCurtis J Donskey
Mar 2, 2012·Emerging Infectious Diseases·Ghinwa DumyatiBrandi Limbago
May 23, 2012·Emerging Infectious Diseases·Jennifer L KuntzDavid H Smith
Nov 5, 2013·World Journal of Gastroenterology : WJG·Daniel E Freedberg, Julian A Abrams
Jun 24, 2014·Aging Health·Robin Lp Jump
Dec 20, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·L M SøesK E P Olsen
Oct 4, 2014·American Journal of Infection Control·Kelly R RevelesChristopher R Frei
Mar 4, 2015·Open Forum Infectious Diseases·Fernanda C LessaScott K Fridkin
Apr 24, 2014·Journal of the American College of Surgeons·Courtney E CollinsHeena P Santry
Jul 3, 2013·The Medical Clinics of North America·Christopher L Knight, Christina M Surawicz
Mar 20, 2013·The American Journal of Medicine·Darlene LeFrancois, Sharon Leung
Jan 13, 2016·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·T Larrainzar-CoghenB Almirante
Apr 17, 2012·Gastroenterology Clinics of North America·Ashwin N Ananthakrishnan
Jul 22, 2011·Current Opinion in Pharmacology·Andrew J StewardsonStephan Harbarth
Oct 30, 2010·Travel Medicine and Infectious Disease·Jaffar A Al-Tawfiq, Mahmoud S Abed
Oct 21, 2015·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Nobuaki Mori, Yasuko Aoki
Jan 5, 2011·Alimentary Pharmacology & Therapeutics·J R GoodhandD S Rampton
Sep 12, 2015·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S YuilleM C Tedford
Apr 4, 2016·Médecine et maladies infectieuses·A PenitD Lepelletier
Apr 6, 2012·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Amelia M KasperUNKNOWN Centers for Disease Control and Prevention Epicenters Program

❮ Previous
Next ❯

Software Mentioned

SAS
MedscapeCME
Office Access

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.